InsidersTradesSigma
Follow the Defence Therapeutics Inc. share price and the full management transaction log of the company, a publicly traded company based in Canada. Shares trade on the CA market, under the supervision of SEDI. Market capitalisation: €38.7m. The latest transaction was disclosed on 6 August 2026 (50 - Grant of options). Among the most active insiders: Beaver, John David. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
Defence Therapeutics Inc. 是一家致力于开发创新癌症治疗方法及其他疾病疗法的公司。该公司在多伦多证券交易所上市，股票代码为 XTSE。